Oncology & Cancer

Synthetic RNAs designed to fight cancer

(Medical Xpress)—In search of better cancer treatments, researchers at Washington University School of Medicine in St. Louis have designed synthetic molecules that combine the advantages of two experimental RNA therapies.

Medical research

Online platform simulates how the body defends itself

A platform that simulates how the body defends itself: The T cells of the immune system decide whether to trigger an immune response against foreign substances. Since December 2013 scientists from around the world can use ...

Oncology & Cancer

CNIO team turns tumor suppressor into anti-cancer target

The laboratory of Marcos Malumbres, who is head of the Spanish National Cancer Research Centre's (CNIO) Cell Division & Cancer Group, working alongside Isabel Fariñas' team from the University of Valencia, shows, in a study ...

Oncology & Cancer

Protein folding becomes cancer treatment target

(Medical Xpress)—A molecule that helps cancer cells to keep dividing could be a promising target for new treatments, according to research published in the journal Oncogene.

Oncology & Cancer

Substance suppresses unchecked leukemia cell division

Scientists of the University of Freiburg and the Freiburg University Medical Center from the collaborative research center Medical Epigenetics (SFB 992) have discovered a new active substance that inhibits cell division in ...

Oncology & Cancer

Biologists ID new cancer weakness

About half of all cancer patients have a mutation in a gene called p53, which allows tumors to survive and continue growing even after chemotherapy severely damages their DNA.

Medical research

New treatment for African sleeping sickness comes closer

Researchers at Umeå University have identified drugs targeting infections of the parasite Trypanosoma brucei and are thereby well on the way to find a cure against African sleeping sickness. This is the kernel of a thesis, ...

page 35 from 40